Ford partners Asthma Society 12 May 2008 21:19, Sligo Weekender
... FORD has announced a partnership with the Asthma Society of Ireland as part of its campaign to improve the lives of the ...

MAP Pharmaceuticals Reports First Quarter of 2008 Financial Results 12 May 2008 20:55, PR Newswire
... Dose Budesonide and MAP0004, in late stage development for the potential treatment of pediatric asthma and migraine respectively. MAP Pharmaceuticals' pipeline also includes a drug candidate in early clinical ...

Isis Pharmaceuticals Inc. Q1 2008 Earnings Call Transcript 12 May 2008 20:55, Seeking Alpha
... Altair Therapeutics just recently began dosing patients with our inhaled antisense drug to treat asthma. We'll not only have an equity stake in Altair as with the rest of ...

Text messages to help teens remember meds 12 May 2008 20:55, Oregon Live
... research suggesting as few as 30 percent of teenagers correctly take medication to prevent asthma attacks. --Among kidney transplant recipients, adolescents have the worst long-term outcomes of any age ...

FDA rejects application for allergy drug 12 May 2008 20:54, Chicago Sun-Times
... the availability or continued use of either Singulair or Claritin. The prescription allergy and asthma pill Singulair is among Merck's best-selling products, with sales of $4.3 billion last year. ...